Insider Transactions in Q2 2024 at Inogen Inc (INGN)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2024
|
Heather D. Rider |
BUY
Grant, award, or other acquisition
|
Direct |
21,871
+27.52%
|
-
|
|
Jun 05
2024
|
Kevin M King |
BUY
Grant, award, or other acquisition
|
Direct |
21,871
+32.1%
|
-
|
|
Jun 05
2024
|
Glenn S Boehnlein |
BUY
Grant, award, or other acquisition
|
Direct |
21,871
+32.1%
|
-
|
|
Jun 05
2024
|
Elizabeth Mora |
BUY
Grant, award, or other acquisition
|
Direct |
21,871
+31.05%
|
-
|
|
Jun 05
2024
|
Mary Kay Ladone |
BUY
Grant, award, or other acquisition
|
Direct |
21,871
+32.1%
|
-
|
|
Jun 05
2024
|
Thomas A. West |
BUY
Grant, award, or other acquisition
|
Direct |
21,871
+34.97%
|
-
|
|
Jun 01
2024
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
339
-6.74%
|
$2,712
$8.3 P/Share
|
|
Jun 01
2024
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
577
+10.29%
|
-
|
|
May 10
2024
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
10,000
-69.19%
|
$80,000
$8.56 P/Share
|
|
May 01
2024
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,695
-34.25%
|
$116,865
$7.05 P/Share
|
|
May 01
2024
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,638
+40.1%
|
-
|
|
May 01
2024
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
11,312
-43.91%
|
$79,184
$7.05 P/Share
|
|
May 01
2024
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
19,276
+42.8%
|
-
|